tirzepatide cardiovascular outcome trial EFFICACY OF IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF 8 RANDOMIZED CLINICAL TRIALS Tirzepatide Improves HFpEF Symptoms and

For researchers modeling type 2 diabetes, insulin resistance, or age-related metabolic decline, MOTS-c offers a holistic approach that improves muscle function and overall physical capacity

Avoid eating within 2 to 3 hours of lying down

Migdalska-Richards A, Schapira AHV

We do not claim to treat, cure, or prevent any conditions or diseases

During inspections, investigators may explicitly ask about AI uses

Abbreviations GLP-1RAs: Glucagon-like peptide-1 receptor agonists T2DM: Type 2 diabetes mellitus DPP-4: Dipeptidyl peptidase IV GLP-1R: Glucagon-like peptide-1 receptor cAMP: Cyclic adenosine monophosphate PKA: Protein kinase A PI3K: Phosphatidylinositol 3-kinase Akt: Protein kinase B AD: Alzheimers diseases TRPV1: Transient receptor potential vanilloid 1 OA: Osteoarthritis KOA: Knee OA MIA: Monoiodoacetate IL-6: Interleukin 6 PGE2: Prostaglandin E2 NO: Nitric oxide ER: Endoplasmic reticulum IL-1: Interleukin-1 MMP-3: Matrix metalloproteinases-3 MMP-13: Matrix metalloproteinases-13 ROS: Reactive oxygen species BMI: Body mass index IBS: Irritable bowel syndrome ATP: Adenosine triphosphate SERT: Serotonin transporter TPH-1: Tryptophan hydroxylase-1 AC: Adenylate cyclase LPS: Lipopolysaccharide WAS: Water avoidance stress IBS-C: Constipation-predominant IBS SNL: Spinal nerve ligation SCI: Spinal cord injury CHOP: C/EBP homologous transcription factor protein GRP78: Glucose regulatory protein 78 PSNT: Partial sciatic nerve transection L